(NAII) Natural Alternatives - Ratings and Ratios

Natural Alternatives International, Inc. is a contract manufacturer and supplier of nutritional supplements, leveraging its expertise to provide customized solutions to clients across various distribution channels, including direct sales, e-commerce, and retail. The companys capabilities extend beyond manufacturing to include strategic partnering services such as product formulation, clinical study design, and regulatory compliance, making it a one-stop-shop for companies seeking to bring nutritional supplements to market.

The companys product portfolio includes a range of formats, such as capsules, tablets, and powders, and it has developed proprietary ingredients like CarnoSyn and SR CarnoSyn, a beta-alanine ingredient used in performance-enhancing supplements. NAIIs client base includes companies operating in the nutritional supplements space, and its services are designed to support clients across the product lifecycle, from formulation to delivery.

Analyzing the technical data, we observe that NAIIs stock price has been trending below its 200-day moving average, indicating a potential downtrend. However, the stock is currently trading above its 20-day and 50-day moving averages, suggesting some short-term bullishness. The ATR indicates a relatively high level of volatility, which could be a concern for investors. Considering the fundamental data, NAIIs market capitalization is approximately $20.15 million, and the company is currently unprofitable, as indicated by the absence of P/E ratios and a negative RoE.

Based on the technical and fundamental data, a potential forecast for NAII is that the stock may continue to experience volatility in the short term, potentially trading within a range of $2.61 to $6.88. However, given the companys negative RoE and lack of profitability, a more likely scenario is that the stock will remain under pressure unless the company can demonstrate significant improvements in its financial performance. A potential catalyst for NAIIs stock could be a turnaround in its financials, potentially driven by increased demand for its contract manufacturing services or the success of its proprietary ingredients. If NAII can achieve profitability, we might see the stock price re-rate, potentially targeting the 52-week high of $6.88.